Skip to main content
logo
Vitrafy Life Sciences Limited (ASX:VFY)
Australia flag Australia · Delayed Price · Currency is AUD
3.810
+0.010 (0.26%)
Aug 26, 2026, 3:58 PM AEST

Vitrafy Life Sciences Financials Overview

Millions AUD. Fiscal year is Jul - Jun.

Revenue & Profits
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Revenue
0.210.211.052.092.061.83
Revenue Growth
-93.29%-80.05%-49.95%1.80%12.63%-
Gross Profit
-8.46-8.46-5.692.092.031.82
Operating Income
-16.78-16.78-14.56-8.64-7.14-4.61
Net Income
-16.17-16.17-32.71-10.43-7.81-7.66
Earnings Per Share
-0.25-0.25-0.73-3.40-2.65-2.62
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Cash & Investments
41.2241.2229.656.451.760.98
Total Debt
0.30.30.3923.339.197.91
Net Cash (Debt)
40.9240.9229.25-16.88-7.43-6.93
Net Cash Growth
82.27%39.88%----
Net Cash Per Share
0.640.640.65-5.50-2.52-2.37

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Operating Cash Flow
-15.77-15.77-8.8-6.79-4.96-5.87
Capital Expenditures
-0.54-0.54-0-0.01-0.09-0.49
Free Cash Flow
-16.31-16.31-8.8-6.8-5.05-6.36
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Gross Margin
---100.00%98.62%99.69%
Operating Margin
-8027.61%-8027.61%-1389.32%-412.48%-347.14%-252.69%
Pretax Margin
-7737.44%-7737.44%-3121.97%-497.98%-379.91%-419.56%
Profit Margin
-7737.44%-7737.44%-3121.97%-497.98%-379.91%-419.56%
FCF Margin
-7804.38%-7804.38%-840.18%-325.03%-245.44%-348.32%

Valuation
Chart
Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingAug '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
PS Ratio
1385.461085.7591.41---